175 related articles for article (PubMed ID: 21305271)
1. Antihypertensive effects exerted by enalapril in mild to moderate hypertension are not associated with changes in the circulating levels of nitric oxide-related markers.
Silva PS; Fontana V; Palei ACT; Sertório JTC; Biagi C; Tanus-Santos JE
Eur J Clin Pharmacol; 2011 Apr; 67(4):365-370. PubMed ID: 21305271
[TBL] [Abstract][Full Text] [Related]
2. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin converting enzyme inhibitors enhance the hypotensive effects of propofol by increasing nitric oxide production.
Oliveira-Paula GH; Pinheiro LC; Ferreira GC; Garcia WNP; Lacchini R; Garcia LV; Tanus-Santos JE
Free Radic Biol Med; 2018 Feb; 115():10-17. PubMed ID: 29138017
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment with sulfhydryl angiotensin-converting enzyme inhibition reduces carotid intima-media thickening and improves the nitric oxide/oxidative stress pathways in newly diagnosed patients with mild to moderate primary hypertension.
Napoli C; Bruzzese G; Ignarro LJ; Crimi E; de Nigris F; Williams-Ignarro S; Libardi S; Sommese L; Fiorito C; Mancini FP; Cacciatore F; Liguori A
Am Heart J; 2008 Dec; 156(6):1154.e1-8. PubMed ID: 19033012
[TBL] [Abstract][Full Text] [Related]
5. The effect of Enalapril on PGI(2) and NO levels in hypertensive patients.
Di Girolamo G; González E; Livio D; de los Santos AR; Martí ML; de Gimeno MA
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(5-6):493-8. PubMed ID: 12144869
[TBL] [Abstract][Full Text] [Related]
6. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Elmarakby AA; Williams JM; Imig JD; Pollock JS; Pollock DM
Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
[TBL] [Abstract][Full Text] [Related]
7. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide synthase tagSNPs influence the effects of enalapril in essential hypertension.
Oliveira-Paula GH; Lacchini R; Luizon MR; Fontana V; Silva PS; Biagi C; Tanus-Santos JE
Nitric Oxide; 2016 May; 55-56():62-9. PubMed ID: 27060232
[TBL] [Abstract][Full Text] [Related]
10. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of antihypertensive therapy with calcium antagonist or angiotensin converting enzyme inhibitor on serum nitrite/nitrate levels in human essential hypertension.
Takase H; Sugiyama M; Nakazawa A; Sato K; Ueda R; Dohi Y
Arzneimittelforschung; 2000 Jun; 50(6):530-4. PubMed ID: 10918945
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension.
Fontana V; Silva PS; Izidoro-Toledo TC; Biagi C; Oliveira EB; Gerlach RF; Tanus-Santos JE
Cardiovasc Drugs Ther; 2012 Dec; 26(6):511-9. PubMed ID: 23085896
[TBL] [Abstract][Full Text] [Related]
13. The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.
Donmez G; Derici U; Erbas D; Arinsoy T; Onk A; Sindel S; Hasanoglu E
Jpn J Physiol; 2002 Oct; 52(5):435-40. PubMed ID: 12533248
[TBL] [Abstract][Full Text] [Related]
14. Effects of ACE inhibition on circulating endothelial progenitor cells, vascular damage, and oxidative stress in hypertensive patients.
Cacciatore F; Bruzzese G; Vitale DF; Liguori A; de Nigris F; Fiorito C; Infante T; Donatelli F; Minucci PB; Ignarro LJ; Napoli C
Eur J Clin Pharmacol; 2011 Sep; 67(9):877-83. PubMed ID: 21445638
[TBL] [Abstract][Full Text] [Related]
15. Gene-Gene Interactions Among PRKCA, NOS3 and BDKRB2 Polymorphisms Affect the Antihypertensive Effects of Enalapril.
Oliveira-Paula GH; Luizon MR; Lacchini R; Fontana V; Silva PS; Biagi C; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):284-291. PubMed ID: 27696692
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats.
García-Estañ J; Ortiz MC; O'Valle F; Alcaraz A; Navarro EG; Vargas F; Evangelista S; Atucha NM
Clin Sci (Lond); 2006 Feb; 110(2):227-33. PubMed ID: 16197366
[TBL] [Abstract][Full Text] [Related]
17. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients.
Qin X; Li Y; Sun N; Wang H; Zhang Y; Wang J; Li J; Xu X; Liang M; Nie J; Wang B; Cheng X; Li N; Sun Y; Zhao L; Wang X; Hou FF; Huo Y
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):166-172. PubMed ID: 27834686
[TBL] [Abstract][Full Text] [Related]
18. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
Rosei EA; Rizzoni D; Muiesan ML; Sleiman I; Salvetti M; Monteduro C; Porteri E;
J Hypertens; 2005 Feb; 23(2):435-44. PubMed ID: 15662233
[TBL] [Abstract][Full Text] [Related]
19. [The effect of acetylsalicylic acid on hypotensive action of enalapril in hypertensive patients].
Przewłocka-Kosmala M
Przegl Lek; 2002; 59(2):76-8. PubMed ID: 12152253
[TBL] [Abstract][Full Text] [Related]
20. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Bayorh MA; Mann G; Walton M; Eatman D
Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
